Kenneth Lim,Matthew Nayor,Eliott Arroyo,Heather N Burney,Xiaochun Li,Yang Li,Ravi Shah,Joseph Campain,Douglas Wan,Stephen Ting,Thomas F Hiemstra,Ravi Thadhani,Sharon Moe,Daniel Zehnder,Martin G Larson,Ramachandran S Vasan,Gregory D Lewis
{"title":"Impairment of Cardiovascular Functional Capacity in Mild to Moderate Kidney Dysfunction.","authors":"Kenneth Lim,Matthew Nayor,Eliott Arroyo,Heather N Burney,Xiaochun Li,Yang Li,Ravi Shah,Joseph Campain,Douglas Wan,Stephen Ting,Thomas F Hiemstra,Ravi Thadhani,Sharon Moe,Daniel Zehnder,Martin G Larson,Ramachandran S Vasan,Gregory D Lewis","doi":"10.2215/cjn.0000000000000548","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nTraditional diagnostic tools that assess resting cardiac function and structure fail to accurately reflect cardiovascular alterations in patients with chronic kidney disease (CKD). This study sought to determine whether multidimensional exercise response patterns related to cardiovascular functional capacity can detect abnormalities in mild-to-moderate CKD.\r\n\r\nMETHODS\r\nIn a cross-sectional study, we examined 3,075 participants from the Framingham Heart Study (FHS) and 451 participants from the Massachusetts General Hospital Exercise Study (MGH-ExS) who underwent cardiopulmonary exercise testing (CPET). Participants were stratified by estimated glomerular filtration rate (eGFR): eGFR ≥90; eGFR 60-89; eGFR 30-59. Our primary outcomes of interest were peak oxygen uptake (VO2Peak),VO2 at anaerobic threshold (VO2AT), and the ratio of minute ventilation to carbon dioxide production (VE/VCO2). Multiple linear regression models were fitted to evaluate the associations between eGFR group and each outcome variable adjusted for covariates.\r\n\r\nRESULTS\r\nIn the FHS cohort, N=1,712 (56%) had an eGFR ≥90 ml/min/1.73m2, N=1,271 (41%) had an eGFR 60-89 ml/min/1.73m2, and N=92 (3%) had an eGFR 30-59 ml/min/1.73m2. In the MGH-ExS cohort, N=247 (55%) had an eGFR ≥90 ml/min/1.73m2, N=154 (34%) had an eGFR 60-89 ml/min/1.73m2, and N=50 (11%) had an eGFR 30-59 ml/min/1.73m2. In FHS, VO2Peak and VO2AT were incrementally impaired with declining kidney function (p<0.001); however this pattern was attenuated following adjustment for age. Percent-predicted VO2Peak at AT was higher in the lower eGFR groups (p<0.001). In MGH-ExS, VO2Peak and VO2AT were incrementally impaired with declining kidney function in unadjusted and adjusted models (p<0.05). VO2Peak was associated with eGFR (p<0.05) in all models even after adjusting for age. On further mechanistic analysis, we directly measured cardiac output (CO) at peak exercise via right heart catheterization and found impaired CO in the lower eGFR groups (p≤0.007).\r\n\r\nCONCLUSION\r\nCPET-derived indices may detect impairment in cardiovascular functional capacity and track cardiac output declines in mild to moderate CKD.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5000,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Journal of the American Society of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2215/cjn.0000000000000548","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND
Traditional diagnostic tools that assess resting cardiac function and structure fail to accurately reflect cardiovascular alterations in patients with chronic kidney disease (CKD). This study sought to determine whether multidimensional exercise response patterns related to cardiovascular functional capacity can detect abnormalities in mild-to-moderate CKD.
METHODS
In a cross-sectional study, we examined 3,075 participants from the Framingham Heart Study (FHS) and 451 participants from the Massachusetts General Hospital Exercise Study (MGH-ExS) who underwent cardiopulmonary exercise testing (CPET). Participants were stratified by estimated glomerular filtration rate (eGFR): eGFR ≥90; eGFR 60-89; eGFR 30-59. Our primary outcomes of interest were peak oxygen uptake (VO2Peak),VO2 at anaerobic threshold (VO2AT), and the ratio of minute ventilation to carbon dioxide production (VE/VCO2). Multiple linear regression models were fitted to evaluate the associations between eGFR group and each outcome variable adjusted for covariates.
RESULTS
In the FHS cohort, N=1,712 (56%) had an eGFR ≥90 ml/min/1.73m2, N=1,271 (41%) had an eGFR 60-89 ml/min/1.73m2, and N=92 (3%) had an eGFR 30-59 ml/min/1.73m2. In the MGH-ExS cohort, N=247 (55%) had an eGFR ≥90 ml/min/1.73m2, N=154 (34%) had an eGFR 60-89 ml/min/1.73m2, and N=50 (11%) had an eGFR 30-59 ml/min/1.73m2. In FHS, VO2Peak and VO2AT were incrementally impaired with declining kidney function (p<0.001); however this pattern was attenuated following adjustment for age. Percent-predicted VO2Peak at AT was higher in the lower eGFR groups (p<0.001). In MGH-ExS, VO2Peak and VO2AT were incrementally impaired with declining kidney function in unadjusted and adjusted models (p<0.05). VO2Peak was associated with eGFR (p<0.05) in all models even after adjusting for age. On further mechanistic analysis, we directly measured cardiac output (CO) at peak exercise via right heart catheterization and found impaired CO in the lower eGFR groups (p≤0.007).
CONCLUSION
CPET-derived indices may detect impairment in cardiovascular functional capacity and track cardiac output declines in mild to moderate CKD.
期刊介绍:
The Clinical Journal of the American Society of Nephrology strives to establish itself as the foremost authority in communicating and influencing advances in clinical nephrology by (1) swiftly and effectively disseminating pivotal developments in clinical and translational research in nephrology, encompassing innovations in research methods and care delivery; (2) providing context for these advances in relation to future research directions and patient care; and (3) becoming a key voice on issues with potential implications for the clinical practice of nephrology, particularly within the United States. Original manuscript topics cover a range of areas, including Acid/Base and Electrolyte Disorders, Acute Kidney Injury and ICU Nephrology, Chronic Kidney Disease, Clinical Nephrology, Cystic Kidney Disease, Diabetes and the Kidney, Genetics, Geriatric and Palliative Nephrology, Glomerular and Tubulointerstitial Diseases, Hypertension, Maintenance Dialysis, Mineral Metabolism, Nephrolithiasis, and Transplantation.